159 related articles for article (PubMed ID: 35726400)
1. Impact of centralization of prostate cancer services on the choice of radical treatment.
Aggarwal A; Han L; Tree A; Lewis D; Roques T; Sangar V; van der Meulen J
BJU Int; 2023 Jan; 131(1):53-62. PubMed ID: 35726400
[TBL] [Abstract][Full Text] [Related]
2. Simulating the impact of centralization of prostate cancer surgery services on travel burden and equity in the English National Health Service: A national population based model for health service re-design.
Aggarwal A; van der Geest SA; Lewis D; van der Meulen J; Varkevisser M
Cancer Med; 2020 Jun; 9(12):4175-4184. PubMed ID: 32329227
[TBL] [Abstract][Full Text] [Related]
3. The Comparative Outcomes of Radical Prostatectomy versus Radiotherapy for Nonmetastatic Prostate Cancer: A Longitudinal, Population-Based Analysis.
Oake JD; Shiff B; Harasemiw O; Tangri N; Ferguson TW; Bhindi B; Saranchuk JW; Bansal RK; Drachenberg DE; Nayak JG
J Urol; 2022 Oct; 208(4):846-854. PubMed ID: 32068493
[TBL] [Abstract][Full Text] [Related]
4. Effect of patient choice and hospital competition on service configuration and technology adoption within cancer surgery: a national, population-based study.
Aggarwal A; Lewis D; Mason M; Purushotham A; Sullivan R; van der Meulen J
Lancet Oncol; 2017 Nov; 18(11):1445-1453. PubMed ID: 28986012
[TBL] [Abstract][Full Text] [Related]
5. Cancer-specific survival after metastasis following primary radical prostatectomy compared with radiation therapy in prostate cancer patients: results of a population-based, propensity score-matched analysis.
Shao YH; Kim S; Moore DF; Shih W; Lin Y; Stein M; Kim IY; Lu-Yao GL
Eur Urol; 2014 Apr; 65(4):693-700. PubMed ID: 23759328
[TBL] [Abstract][Full Text] [Related]
6. External beam radiotherapy versus radical prostatectomy for clinical stage T1-2 prostate cancer: therapeutic implications of stratification by pretreatment PSA levels and biopsy Gleason scores.
Kupelian P; Katcher J; Levin H; Zippe C; Suh J; Macklis R; Klein E
Cancer J Sci Am; 1997; 3(2):78-87. PubMed ID: 9099457
[TBL] [Abstract][Full Text] [Related]
7. Improved biochemical outcome with adjuvant radiotherapy after radical prostatectomy for prostate cancer with poor pathologic features.
Vargas C; Kestin LL; Weed DW; Krauss D; Vicini FA; Martinez AA
Int J Radiat Oncol Biol Phys; 2005 Mar; 61(3):714-24. PubMed ID: 15708249
[TBL] [Abstract][Full Text] [Related]
8. The impact of transportation mode, socioeconomic deprivation and rurality on travel times to radiotherapy and surgical services for patients with prostate cancer: A national population-based evaluation.
Han L; Sullivan R; Tree A; Lewis D; Price P; Sangar V; van der Meulen J; Aggarwal A
Radiother Oncol; 2024 Mar; 192():110092. PubMed ID: 38219910
[TBL] [Abstract][Full Text] [Related]
9. Positive surgical margins: rate, contributing factors and impact on further treatment: findings from the Prostate Cancer Registry.
Evans SM; Millar JL; Frydenberg M; Murphy DG; Davis ID; Spelman T; Bolton DM; Giles GG; Dean J; Costello AJ; Frauman AG; Kearns PA; Day L; Daniels C; McNeill JJ
BJU Int; 2014 Nov; 114(5):680-90. PubMed ID: 24128010
[TBL] [Abstract][Full Text] [Related]
10. Impact of surgical margin status on prostate-cancer-specific mortality.
Chalfin HJ; Dinizo M; Trock BJ; Feng Z; Partin AW; Walsh PC; Humphreys E; Han M
BJU Int; 2012 Dec; 110(11):1684-9. PubMed ID: 22788795
[TBL] [Abstract][Full Text] [Related]
11. Comparison of the efficacy of local therapies for localized prostate cancer in the prostate-specific antigen era: a large single-institution experience with radical prostatectomy and external-beam radiotherapy.
Kupelian PA; Elshaikh M; Reddy CA; Zippe C; Klein EA
J Clin Oncol; 2002 Aug; 20(16):3376-85. PubMed ID: 12177097
[TBL] [Abstract][Full Text] [Related]
12. Are biochemical recurrence outcomes similar after radical prostatectomy and radiation therapy? Analysis of prostate cancer-specific mortality by nomogram-predicted risks of biochemical recurrence.
Lee BH; Kibel AS; Ciezki JP; Klein EA; Reddy CA; Yu C; Kattan MW; Stephenson AJ
Eur Urol; 2015 Feb; 67(2):204-9. PubMed ID: 25294696
[TBL] [Abstract][Full Text] [Related]
13. Overview of potential determinants of radical prostatectomy versus radiation therapy in management of clinically localized prostate cancer: results from an Italian, prospective, observational study (the Pros-IT CNR study).
Antonelli A; Palumbo C; Noale M; Artibani W; Bassi P; Bertoni F; Bracarda S; Bruni A; Corvò R; Gacci M; Magrini SM; Montironi R; Porreca A; Tubaro A; Zagonel V; Maggi S;
Minerva Urol Nefrol; 2020 Oct; 72(5):595-604. PubMed ID: 31920063
[TBL] [Abstract][Full Text] [Related]
14. Stage T1-2 prostate cancer with pretreatment prostate-specific antigen level < or = 10 ng/ml: radiation therapy or surgery?
Keyser D; Kupelian PA; Zippe CD; Levin HS; Klein EA
Int J Radiat Oncol Biol Phys; 1997 Jul; 38(4):723-9. PubMed ID: 9240638
[TBL] [Abstract][Full Text] [Related]
15. Identification of factors predicting response to adjuvant radiation therapy in patients with positive margins after radical prostatectomy.
Kamat AM; Babaian K; Cheung MR; Naya Y; Huang SH; Kuban D; Babaian RJ
J Urol; 2003 Nov; 170(5):1860-3. PubMed ID: 14532793
[TBL] [Abstract][Full Text] [Related]
16. Measuring prostate-specific quality of life in prostate cancer patients scheduled for radiotherapy or radical prostatectomy and reference men in Germany and Canada using the Patient Oriented Prostate Utility Scale-Psychometric (PORPUS-P).
Waldmann A; Rohde V; Bremner K; Krahn M; Kuechler T; Katalinic A
BMC Cancer; 2009 Aug; 9():295. PubMed ID: 19698163
[TBL] [Abstract][Full Text] [Related]
17. Hospital Quality Factors Influencing the Mobility of Patients for Radical Prostate Cancer Radiation Therapy: A National Population-Based Study.
Aggarwal A; Lewis D; Sujenthiran A; Charman SC; Sullivan R; Payne H; Mason M; van der Meulen J
Int J Radiat Oncol Biol Phys; 2017 Dec; 99(5):1261-1270. PubMed ID: 28964586
[TBL] [Abstract][Full Text] [Related]
18. Predictors of prostate cancer-specific mortality after radical prostatectomy or radiation therapy.
Zhou P; Chen MH; McLeod D; Carroll PR; Moul JW; D'Amico AV
J Clin Oncol; 2005 Oct; 23(28):6992-8. PubMed ID: 16192586
[TBL] [Abstract][Full Text] [Related]
19. Radical prostatectomy for clinical T4 prostate cancer.
Johnstone PA; Ward KC; Goodman M; Assikis V; Petros JA
Cancer; 2006 Jun; 106(12):2603-9. PubMed ID: 16700037
[TBL] [Abstract][Full Text] [Related]
20. Differential impact of radiation therapy after radical prostatectomy on recurrence patterns: an assessment using [
Grubmüller B; Jahrreiss V; Huebner N; Mitterhauser M; Stangl-Kremser J; Grubmüller KH; Baltzer P; Hacker M; Goldner G; Shariat SF; Rasul S
Prostate Cancer Prostatic Dis; 2021 Jun; 24(2):439-447. PubMed ID: 32994534
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
